Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF -2-
July 9, 2001
- 4,310 ADRs Reported by Monitor Pharmacies in Tokyo in 10 Years
July 9, 2001
- REGULATORY NEWS IN BRIEF -1-
July 9, 2001
- Japanese Makers' Globalization Discussed: Interphex Japan
July 9, 2001
- Safety Info. No. 267 Focuses on Reye Syndrome Due to Salicylate
July 9, 2001
- Yamanouchi Forms Alliance with Celera Genomics
July 9, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 9, 2001
- JPMA to Propose New Drug Benefit System: Mr Nagayama
July 9, 2001
- Non-member Countries' Interest in ICH to Be Surveyed
July 9, 2001
- Sysmex: POC Test Information System
July 9, 2001
- JMA Proposes New Medical Fee Payment System by Type of Medical Institution
July 9, 2001
- MEDICAL DEVICE NEWS IN BRIEF
July 2, 2001
- Kyowa Hakko to Sell Mohan to Merck Hoei
July 2, 2001
- WORLD NEWS IN BRIEF
July 2, 2001
- Dainippon Launches Gasmotin in China
July 2, 2001
- OTC NEWS IN BRIEF
July 2, 2001
- EAD Director Urges Generic Houses to Expand Their Sales Route
July 2, 2001
- Takeda to Invest \110 Billion in R&D for FY2001
July 2, 2001
- 14 New Ingredients Officially Clear Regulatory Approval
July 2, 2001
- Long-term Continuous Use of Rocornal Reduces Cardiac Events
July 2, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…